Kintsugi raises an $8M seed round to expand enterprise commercialization of rapid, voice-based mental health screenings.

Kintsugi (EFL Deep Tech, 2021) uses voice biomarkers to measure and predict well-being by scoring clinical depression and anxiety on standard PHQ-9/GAD-7 instruments from less than a minute of free-form speech.